Administration & Agency Updates

Recent Administration & Agency Updates

nihb_blog_default
  • September 24, 2021·

CDC Endorsed Booster Shots for Millions of Older or Otherwise Vulnerable Americans

On Thursday, September 24, 2021, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended a booster shot of the Pfizer-BioNTech COVID-19 vaccine for a wide range of Americans. CDC Director Dr. Rochelle Walensky endorsed the ACIP recommendations and added an additional recommendation for those in high risk occupational and institutional settings, which is in line with the Food…
Learn More
nihb_blog_default
  • September 21, 2021·

Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.

On September 21, 2021 Johnson & Johnson (J&J) announced new data supporting the long-lasting protection of its COVID-19 vaccine. Data also indicated that protection against COVID-19 increases when a booster shot of the J&J vaccine is administered. Data showed a booster increased protection by 94% when given at two months, a four-fold increase in antibodies when given at two months, and a 12-fold increase…
Learn More
  • September 19, 2021·

Disparities in Excess Mortality Associated with COVID-19 – CDC Report

The Centers for Disease Control and Prevention (CDC) released a study showing that non-Hispanic American Indian/Alaska Native (AI/AN) populations have been disproportionately affected by the COVID-19 pandemic. During the COVID-19 pandemic in 2020, Black and AI/AN persons had the highest excess all-cause mortality incidence rates among those aged under 25 years and those 25–64 years old, whereas among adults older than 65 years old,…
Learn More
  • September 19, 2021·

Use of Rapid Antigen Testing for SARS-CoV-2 in Remote Communities — Yukon-Kuskokwim Delta Region

A Morbidity and Mortality Weekly Report (MMWR) released by the Centers for Disease Control and Prevention (CDC) examined the use of rapid point-of-care antigen testing in the Yukon-Kuskokwim Delta Region of Alaska. Controlling the spread of SARS-CoV-2, the virus that causes COVID-19, in Alaska is challenging in rural areas due to the slow turnaround times for SARS-CoV-2 test results, attributable to the need to…
Learn More
nihb_blog_default
  • September 19, 2021·

CDC Disaster Shelter Assessment

The Centers for Disease Control and Prevention (CDC) has developed the Environmental Health Assessment Form and Instruction Sheet for Disaster Shelters to assist environmental health practitioners in conducting a rapid assessment of shelter conditions during emergencies and disasters. The tool is an assessment form that covers 10 general areas of environmental health, ranging from basic food safety and water quality to pet (companion animal)…
Learn More
  • September 16, 2021·

FDA Statement on Vaccines for Younger Children

Janet Woodcock, M.D. Acting Commissioner of Food and Drugs – Food and Drug Administration (FDA), and Peter Marks, M.D., PhD. Director – Center for Biologics Evaluation and Research (CBER) shared information about the process and the necessary considerations involved to provide greater clarity to the public about vaccines for children under 12 years of age. Because young children are still growing and developing, it’s important that…
Learn More

Contact Us

To reach the NIHB COVID-19 Response Team, please contact COVID@nihb.org.

For media inquiries, please contact Ned Johnson at njohnson@nihb.org.

Facebook Twitter Instagram Youtube

© Copyright 2020, National Indian Health Board. All Rights Reserved. Website by DrawBridge Creative.

Privacy Policy

This website is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of financial assistance awards totaling $2,000,000, Tribal Capacity Building for COVID-19 Disease Control, and $4,000,000, Addressing COVID-19 Vaccine Confidence Through Tribal Health Departments, with 80 percent funded by CDC/HHS, and 20 percent funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.